Fig. 1From: Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expressionDiagram outlining the selection of patients with SI-and P-NET for the final analysesBack to article page